Raymond James Financial Services Advisors, Inc. Atai Life Sciences N.V. Transaction History
Raymond James Financial Services Advisors, Inc.
- $73.5 Billion
- Q3 2024
A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Atai Life Sciences N.V. stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 29,571 shares of ATAI stock, worth $165,006. This represents 0.0% of its overall portfolio holdings.
Number of Shares
29,571
Previous 12,946
128.42%
Holding current value
$165,006
Previous $17,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ATAI
# of Institutions
111Shares Held
31.3MCall Options Held
494KPut Options Held
315K-
Ubs Group Ag7.7MShares$43 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.43MShares$30.3 Million0.02% of portfolio
-
Morgan Stanley New York, NY3.49MShares$19.5 Million0.0% of portfolio
-
Pale Fire Capital Se Prague, 2N2.64MShares$14.7 Million0.59% of portfolio
-
Black Rock Inc. New York, NY1.31MShares$7.29 Million0.0% of portfolio
About ATAI Life Sciences N.V.
- Ticker ATAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 165,875,008
- Market Cap $926M
- Description
- Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...